AAAAAA
Results: 1-25/161
Authors:
MAUSKOP A
Citation: A. Mauskop, NEUROBIOLOGY OF MIGRAINE - INTRODUCTION, Clinical neuroscience, 5(1), 1998, pp. 1-1
Authors:
LIPTON RB
STEWART WF
Citation: Rb. Lipton et Wf. Stewart, MIGRAINE HEADACHES - EPIDEMIOLOGY AND COMORBIDITY, Clinical neuroscience, 5(1), 1998, pp. 2-9
Authors:
SCHOENEN J
Citation: J. Schoenen, CORTICAL ELECTROPHYSIOLOGY IN MIGRAINE AND POSSIBLE PATHOGENETIC IMPLICATIONS, Clinical neuroscience, 5(1), 1998, pp. 10-17
Authors:
GOADSBY PJ
Citation: Pj. Goadsby, SEROTONIN RECEPTORS AND THE ACUTE ATTACK OF MIGRAINE, Clinical neuroscience, 5(1), 1998, pp. 18-23
Authors:
MAUSKOP A
ALTURA BM
Citation: A. Mauskop et Bm. Altura, ROLE OF MAGNESIUM IN THE PATHOGENESIS AND TREATMENT OF MIGRAINES, Clinical neuroscience, 5(1), 1998, pp. 24-27
Authors:
THOMSEN LL
OLESEN J
Citation: Ll. Thomsen et J. Olesen, NITRIC-OXIDE THEORY OF MIGRAINE, Clinical neuroscience, 5(1), 1998, pp. 28-33
Authors:
PEROUTKA SJ
Citation: Sj. Peroutka, GENETIC-BASIS OF MIGRAINE, Clinical neuroscience, 5(1), 1998, pp. 34-37
Authors:
MANNIX LK
SOLOMON GD
Citation: Lk. Mannix et Gd. Solomon, QUALITY-OF-LIFE IN MIGRAINE, Clinical neuroscience, 5(1), 1998, pp. 38-42
Authors:
VANHOOK E
Citation: E. Vanhook, NON PHARMACOLOGICAL TREATMENT OF HEADACHES - WHY, Clinical neuroscience, 5(1), 1998, pp. 43-49
Authors:
WARD TN
Citation: Tn. Ward, MANAGEMENT OF AN ACUTE PRIMARY HEADACHE, Clinical neuroscience, 5(1), 1998, pp. 50-54
Authors:
RAPOPORT AM
Citation: Am. Rapoport, PHARMACOLOGICAL PREVENTION OF MIGRAINE, Clinical neuroscience, 5(1), 1998, pp. 55-59
Authors:
COMI G
THOMAS PK
Citation: G. Comi et Pk. Thomas, NEUROLOGICAL COMPLICATIONS OF DIABETES - INTRODUCTION, Clinical neuroscience, 4(6), 1997, pp. 321-321
Authors:
MOORADIAN AD
Citation: Ad. Mooradian, PATHOPHYSIOLOGY OF CENTRAL-NERVOUS-SYSTEM COMPLICATIONS IN DIABETES-MELLITUS, Clinical neuroscience, 4(6), 1997, pp. 322-326
Authors:
NIEMEYER G
Citation: G. Niemeyer, GLUCOSE-CONCENTRATION AND RETINAL FUNCTION, Clinical neuroscience, 4(6), 1997, pp. 327-335
Authors:
LOPEZ L
SANNITA WG
Citation: L. Lopez et Wg. Sannita, GLUCOSE AVAILABILITY AND THE ELECTROPHYSIOLOGY OF THE HUMAN VISUAL-SYSTEM, Clinical neuroscience, 4(6), 1997, pp. 336-340
Authors:
THOMAS PK
Citation: Pk. Thomas, CLINICAL-FEATURES AND INVESTIGATION OF DIABETIC SOMATIC PERIPHERAL NEUROPATHY, Clinical neuroscience, 4(6), 1997, pp. 341-345
Authors:
SPALLONE V
MENZINGER G
Citation: V. Spallone et G. Menzinger, AUTONOMIC NEUROPATHY - CLINICAL AND INSTRUMENTAL FINDINGS, Clinical neuroscience, 4(6), 1997, pp. 346-358
Authors:
SIMA AAF
CHERIAN PV
Citation: Aaf. Sima et Pv. Cherian, NEUROPATHOLOGY OF DIABETIC NEUROPATHY AND ITS CORRELATIONS WITH NEUROPHYSIOLOGY, Clinical neuroscience, 4(6), 1997, pp. 359-364
Authors:
FELDMAN EL
STEVENS MJ
GREENE DA
Citation: El. Feldman et al., PATHOGENESIS OF DIABETIC NEUROPATHY, Clinical neuroscience, 4(6), 1997, pp. 365-370
Authors:
CANAL N
NEMNI R
Citation: N. Canal et R. Nemni, AUTOIMMUNITY AND DIABETIC NEUROPATHY, Clinical neuroscience, 4(6), 1997, pp. 371-373
Authors:
COMI G
Citation: G. Comi, EVOKED-POTENTIALS IN DIABETES-MELLITUS, Clinical neuroscience, 4(6), 1997, pp. 374-379
Authors:
HOUNSOM L
TOMLINSON DR
Citation: L. Hounsom et Dr. Tomlinson, DOES NEUROPATHY DEVELOP IN ANIMAL-MODELS, Clinical neuroscience, 4(6), 1997, pp. 380-389
Authors:
BODISWOLLNER I
Citation: I. Bodiswollner, OPTIC-NERVE DISEASE - AN INTRODUCTION, Clinical neuroscience, 4(5), 1997, pp. 213-215
Authors:
ROTH S
Citation: S. Roth, ROLE OF NITRIC-OXIDE IN RETINAL CELL-DEATH, Clinical neuroscience, 4(5), 1997, pp. 216-223
Authors:
ROSENBAUM PS
GUPTA H
SAVITZ SI
ROSENBAUM DM
Citation: Ps. Rosenbaum et al., APOPTOSIS IN THE RETINA, Clinical neuroscience, 4(5), 1997, pp. 224-232